SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-008331
Filing Date
2012-08-14
Accepted
2012-08-13 18:15:34
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atheronova_10q-063012.htm 10-Q 802941
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15792
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16639
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6549
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 7169
  Complete submission text file 0001437749-12-008331.txt   5594176

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE ahro-20120630.xml EX-101.INS 838853
7 XBRL TAXONOMY EXTENSION SCHEMA ahro-20120630.xsd EX-101.SCH 42924
8 XBRL TAXONOMY EXTENSION CALCULATION ahro-20120630_cal.xml EX-101.CAL 29698
9 XBRL TAXONOMY EXTENSION DEFINITION ahro-20120630_def.xml EX-101.DEF 262776
10 XBRL TAXONOMY EXTENSION LABELS ahro-20120630_lab.xml EX-101.LAB 359089
11 XBRL TAXONOMY EXTENSION PRESENTATION ahro-20120630_pre.xml EX-101.PRE 271686
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

IRS No.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52315 | Film No.: 121028850
SIC: 2834 Pharmaceutical Preparations